Vadadustat
AKB-6548-CI-0003
Phase 2 small_molecule completed
Quick answer
Vadadustat for Chronic Kidney Disease is a Phase 2 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Chronic Kidney Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed